A hormonal association between estrogen metabolism and proliferative thyroid disease

被引:18
作者
Chan, EK
Sepkovic, DW
Bowne, HJY
Yu, GP
Schantz, SP
机构
[1] New York Eye & Ear Infirm, New York Med Coll, Dept Otolaryngol Head & Neck Surg, New York, NY 10003 USA
[2] Hackensack Univ, Med Ctr, Hackensack, NJ 07601 USA
[3] New York Eye & Ear Infirm, Dept Otolaryngol Head & Neck Surg, New York, NY USA
[4] New York Eye & Ear Infirm, St Vincents Hosp Manhattan, New York, NY USA
关键词
D O I
10.1016/j.otohns.2006.01.020
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
OBJECTIVE: To illustrate a relationship between proliferative thyroid disease and estrogen metabolism through the analysis of urinary estrogen metabolites. STUDY DESIGN AND SETTING: Case-control study of 49 subjects with proliferative thyroid disorders and matching them to 49 controls. Urinary estrogen metabolite ratios were obtained, measuring 2-hydroxyestrone, an anti-proliferative metabolite, to 16 alpha-hydroxyestrone, a proliferative metabolite. The patients were stratified into low (0 to 1.00), medium (1.01 to 2.00), or high (> 2.00) groups according to their estrogen metabolite ratio. RESULTS: Fifty-one percent (25 of 49) of the cases had a low 2/16 ratio compared to 31% (15 of 49) in the control group while 20% (10 of 49) of the control group had a high 2/16 ratio as compared to 8% (4 of 49) in the case group (P value < 0.05). CONCLUSIONS: increased 16 alpha-hydroxyestrone activity compared to 2-hydroxyestrone activity appears to be associated with proliferative thyroid disease. SIGNIFICANCE: Further study of estrogen metabolites in relation to proliferative thyroid disease is warranted and may lead to implications for new treatment modalities for proliferative thyroid disease.
引用
收藏
页码:893 / 900
页数:8
相关论文
共 21 条
[1]   Role of the estrogen receptor in the action of organochlorine pesticides on estrogen metabolism in human breast cancer cell lines [J].
Bradlow, HL ;
Davis, D ;
Sepkovic, DW ;
Tiwari, R ;
Osborne, MP .
SCIENCE OF THE TOTAL ENVIRONMENT, 1997, 208 (1-2) :9-14
[2]  
Chen AY, 2001, CANCER-AM CANCER SOC, V92, P225, DOI 10.1002/1097-0142(20010715)92:2<225::AID-CNCR1313>3.0.CO
[3]  
2-B
[4]  
FISHMAN J, 1960, J BIOL CHEM, V235, P3104
[5]  
Galofre J C, 1994, Thyroidology, V6, P49
[6]  
Horn-Ross PL, 2002, CANCER EPIDEM BIOMAR, V11, P43
[7]   Low goitre prevalence among users of oral contraceptives in a population sample of 3712 women [J].
Knudsen, N ;
Bülow, I ;
Laurberg, P ;
Perrild, H ;
Ovesen, L ;
Jorgensen, T .
CLINICAL ENDOCRINOLOGY, 2002, 57 (01) :71-76
[8]   Estrogens in female thyroid cancer: alteration of urinary profiles in pre- and post-operative cases [J].
Lee, SH ;
Kim, KM ;
Jung, BH ;
Chung, WY ;
Park, CS ;
Chung, BC .
CANCER LETTERS, 2003, 189 (01) :27-32
[9]  
Lewy-Trenda Iwona, 2002, Polish Journal of Pathology, V53, P67
[10]   Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms [J].
Manole, D ;
Schildknecht, B ;
Gosnell, B ;
Adams, E ;
Derwahl, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1072-1077